LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
35,321,668
Share change
+691,122
Total reported value
$272,681,447
Put/Call ratio
5.4%
Price per share
$7.72
Number of holders
80
Value change
+$6,740,395
Number of buys
41
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q4 2015

As of 31 Dec 2015, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,321,668 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, RS INVESTMENT MANAGEMENT CO LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, ACUTA CAPITAL PARTNERS, LLC, BAKER BROS. ADVISORS LP, BlackRock Fund Advisors, and VANGUARD GROUP INC. This page lists 80 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.